|
Active substance |
Tocilizumab |
|
Holder |
Roche |
|
Status |
Closed |
|
Indication |
Systemic sclerosis |
|
Public documents |
|
|
Dernière mise à jour |
03/09/2018 |
RoACTEMRA®
Last updated on 10/09/2024